CDC Online Newsroom - CDC Advisory - CDC Statement on Oseltamivir (Tamiflu) Resistance and Antiviral Recommendations

This page is a historical archive and is no longer maintained.

For current information, please visit http://www.cdc.gov/media/

Media Advisory

For Immediate Release: Jaunary 9, 2009
Contact: Division of News & Electronic Media, Office of Communication
(404) 639-3286

CDC Statement on Oseltamivir (Tamiflu) Resistance and Antiviral Recommendations

 

Important instructions:

If you would like to ask a question during the call, press *1 on your touchtone phone. Press *2 to withdraw your question. You may queue up at any time. You will hear a tone to indicate your question is pending.

LISTEN-ONLY AUDIO WEBCAST

This media availability will also available via listen-only audio web cast at www.cdc.gov/media.

TRANSCRIPT

A transcript of this media availability will be available following the briefing at the CDC web site at www.cdc.gov/media.

###
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES

Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • Contact CDC–INFO